Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates...
المؤلفون الرئيسيون: | López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
MDPI
2019
|
مواد مشابهة
-
Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
حسب: César López-Camacho, وآخرون
منشور في: (2019-11-01) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
حسب: Moorthy, V, وآخرون
منشور في: (2003) -
New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
حسب: Alharbi, N
منشور في: (2014) -
Clinical development of Modified Vaccinia virus Ankara vaccines.
حسب: Gilbert, S
منشور في: (2013) -
Clinical development of Modified Vaccinia virus Ankara vaccines
حسب: Gilbert, S
منشور في: (2013)